Top Markets
Coin of the day
Avidity Biosciences Inc Avidity Biosciences Inc

Avidity Biosciences Inc

RNAM
Pozycja w akcjach #2179
Avidity Biosciences, Inc. is at the forefront of developing a novel class of... Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.
Cena akcji
$71.34
Ostatnia synchronizacja: 2026-03-03
Kapitalizacja rynkowa
$9.84B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-
Kraj
US
Handel Avidity Biosciences Inc (RNAM)

Kategoria

Historia stopy dywidendy dla Avidity Biosciences Inc (RNAM)
Stopa dywidendy (TTM) dla Avidity Biosciences Inc (symbol akcji: RNAM) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Avidity Biosciences Inc (RNAM) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji